SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-17-000481
Filing Date
2017-08-11
Accepted
2017-08-11 17:07:54
Documents
65
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bioptix_10q-063017.htm 10-Q 596602
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 9733
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 9110
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 7841
11 image0.jpg GRAPHIC 37246
  Complete submission text file 0001079973-17-000481.txt   4626460

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT biop-20170630.xml EX-101.INS 818395
6 XBRL TAXONOMY EXTENSION SCHEMA biop-20170630.xsd EX-101.SCH 48846
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biop-20170630_cal.xml EX-101.CAL 73657
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biop-20170630_def.xml EX-101.DEF 249619
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE biop-20170630_lab.xml EX-101.LAB 442704
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biop-20170630_pre.xml EX-101.PRE 354426
Mailing Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104
Business Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104 303-794-2000
Bioptix, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 171025977
SIC: 2835 In Vitro & In Vivo Diagnostic Substances